| Literature DB >> 30524481 |
José Eranildo Teles do Nascimento1,2, Ana Livya Moreira Rodrigues3, Daniele Silva de Lisboa4, Hortência Ribeiro Liberato5, Maria José Cajazeiras Falcão5, Cecília Rocha da Silva6,7, Hélio Vitoriano Nobre Júnior6, Raimundo Braz Filho8,9, Valdir Ferreira de Paula Junior1, Daniela Ribeiro Alves1, Selene Maia de Morais1,3,4.
Abstract
Ouratea fieldingiana (Gardner) Engl is popularly used for wound healing. This study describes the main chemical compounds present in extracts of O. fieldingiana and evaluates their biological potential by investigating antifungal, antioxidant, and anticholinesterase activities. The action mechanism of main antifungal compound was investigated by molecular docking using the enzyme sterol 14-α demethylase, CYP51, required for ergosterol biosynthesis. The seeds and leaves were extracted with ethanol in a Soxhlet apparatus and by maceration, respectively. Both extracts were subjected to silica gel column chromatography for isolation of main constituents, followed by purification in sephadex. The structures of compounds were established by 1H and 13C-NMR spectroscopy and identified by comparison with literature data as amentoflavone and kaempferol 3-O-rutinoside, respectively. The antioxidant activities of the extracts were determined by the DPPH and ABTS free radical inhibition methods. In general, the extracts with the highest antioxidant activity corresponded to those with higher content of phenolic compounds and flavonoids. The ethanol extracts and two isolated compounds presented relevant antifungal activity against several Candida strains. The in silico findings revealed that the compound amentoflavone coupled with the CYP450 protein due to the low energy stabilization (-9.39 kcal/mol), indicating a possible mechanism of action by inhibition of the ergosterol biosynthesis of Candida fungi.Entities:
Year: 2018 PMID: 30524481 PMCID: PMC6247570 DOI: 10.1155/2018/1748487
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Chemical representation of compounds present in Ouratea fieldingiana.
Evaluation of acetylcholinesterase inhibition action of extracts and constituents of Ouratea fieldingiana.
| Extract | IC50 in ELISA ( |
|---|---|
| Leaf ethanol extract | 0.816 ± 0.004a |
| Branch ethanol extract | 11.89 ± 0.048b |
| Leaf ethanol extract (MF) | 36.81 ± 0.024d |
| Branch ethanol extract (EAF) | 57.58 ± 0.088e |
| Seed hexane extract | 20.51 ± 0.387c |
| Seed ethanol extract | 12.15 ± 0.003b |
| Seed aqueous extract | 9.19 ± 0.030b |
| Kaempferol-3- | 17.70 ± 0.030c |
| Amentoflavone | 11.92 ± 0.046b |
| Physostigmine (standard) | 1.15 ± 0.046a |
| Eserine (standard; Penido et al., 2016) | 19.53 ± 0.08c |
Data presented are mean ± standard deviation, according to ANOVA followed by the Tukey test. Values with different small letters differ statistically (p<0.05); EAF: ethyl acetate fraction; MF: methanol fraction.
Evaluation of the antifungal effect of Ouratea fieldingina extracts against Candida spp.
| MIC 50/100 b( | ||||
|---|---|---|---|---|
| Strainsa | ||||
| Extracts | ATCC | ATCC |
|
|
| SHE | >1000 / >1000 | >1000/>1000 | >1000/>1000 | >1000/ >1000 |
| LEE | 500 / > 1000 | 7.8 / 31.25 | 500 / > 1000 | 500 / > 1000 |
| LEE (MF) | 500 / > 1000 | 3.9 / 31.25 | 1000 / > 1000 | 125 / > 1000 |
| BEE (EAF) | 125 / 500 | 62.5 / 250 | 500 / > 1000 | 500 / > 1000 |
| BEE | 15.62 / > 1000 | 1.95 / 15.6 | 250 / > 1000 | 62.5 / > 1000 |
| SEE | 250 / 1000 | 62.5 / 250 | 1000 / > 1000 | 1000 / >1000 |
aYeast strains isolated from collection. bMIC was defined as the lowest concentration which produced 50% and 100% reduction of fungal cell growth after 24 h incubation. cThe procedure was performed according to protocol M27-A3 of CLSI 2008. The range of compounds tested varied from 1000 to 1.95 μg/mL. SHE: seed hexane extract; LEE: leaf ethanol extract; LEE (MF): leaf ethanol extract (methanol fraction): BEE: branch ethanol extract, BEE (EAF): branch ethanol extract (ethyl acetate fraction), and SEE: seed ethanol extract.
Evaluation of antifungal effect of amentoflavone and kaempferol against Candida spp. Isolates.
|
| ||||
|---|---|---|---|---|
| Strainsa | ||||
| Compounds | ATCC | ATCC | ATCC |
|
| Amentoflavone | 125 | 15.62 | 15.62 | 250 |
| Kaempferol 3- | > 500 | 250 | 125 | > 500 |
| Amentoflavone | 1.25 | 1.25 | 0.625 | 2.5 |
aYeast cells isolated from collection. bMIC was defined as the lowest concentration which produced 50% reduction of fungal cell growth after 24 h incubation. The procedure was performed according to protocol M27-A3 of CLSI 2008. The concentrations of compounds tested ranged from 500 to 0.97 μg/mL.
Figure 2Optimization of the geometry of the amentoflavone molecule. (a) Before energy minimization by the MMFF94 force field. (b) After energy minimization by the application of the force field MMFF94.
Figure 3Overlap of the itraconazole binders to the catalytic site of the protein CYP51.
Figure 4Conformation of compound submitted to the computational test. (Itraconazole) Pose obtained from re-docking molecule. (PDB-5v5z) Itraconazole complexed the CYP51 protein in its native conformation.
Figure 5Molecular docking of amentoflavone with the CYP51 protein, characterizing the residues involved in the hydrophobic interaction and hydrogen bond.
Phenol and flavonoids content and antioxidant activity of O. fieldingiana extracts.
| Extracts and constituents |
|
|
|
|
|---|---|---|---|---|
|
|
|
| ||
|
| 35.33 ± 22.15b | 8.978 ± 0.267a | 4.953 ± 0.884a | 5.117±2.605a |
|
| 16.03 ± 14.29 | 3.798 ± 0.284 | 64.345 ± 0.227 | 63.210±1.577d |
|
| 12.70 ± 8.38 | 1.261 ± 0.929 | 72.436 ± 0.359 | 59.613±1.916d |
|
| 23.30 ± 16.93b | 5.216 ± 0.523 | 57.147 ± 2.085 | 9.654±0.161b |
|
| 26.89 ± 9.46a | 8.657 ± 0.195a | 5.394 ± 0.03a | 5.235±0.195a |
|
| 61.81 ± 7.15a | 7.225 ± 0.779a | 5.898 ± 0.291a | 4.195±0.0283a |
|
| 9.60 ± 3.39 | 1.517 ± 0.241 | 310.486 ± 34.743 | 194.213±3.418d |
|
| 8.013 ± 7.403 | 1.259 ± 0.094 | 108.386 ± 4.653 | 31.753±2.386d |
|
| 32.07 ± 1.29b | 4.283 ± 0.123 | 7.577 ± 0.216a | 6.166±0.164a |
|
| 13.69 ± 6.99 | 0.979 ± 0.198 | 63.433 ± 3.456 | 62.455±0.018d |
|
| 7.344±1.1482 | 0.229±0.0721 | 31.324±6.289 | 23.898±1.036c |
|
| 6.007±3.007 | 0.688±0.095 | 71.092±1.116 | 27.676±0.467c |
|
| 46.274±19.6a | 5.849±0.296 | 16.096±0.636 | 64.228±0.298d |
|
| - | - | 35.612±2.440 | 83.306±2.6354d |
|
| - | - | 30.962±1.5317 | 75.752±6.082d |
|
| - | - | 4.779 ± 0.507a | 1.738±0.089a |
Total phenols are quantified in milligrams per gallic acid equivalent. Flavonoids are quantified in milligrams per quercetin equivalent. Confidence interval: 95%; LEE: leaf ethanol extract (LEE), BEE: branch ethanol extract, SEF: seed ethanol fraction, SEE: seed ethanol extract, and SAE: seed aqueous extract. HE: hexane fraction, CF: chloroform fraction, EAF: ethyl acetate fraction, and MF: methanol fraction.